CIPRO XR bulk active fine chemical vendors

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
Vitas-M Laboratory	⤷ Get Started Free	STK021082	⤷ Get Started Free
Molport	⤷ Get Started Free	MolPort-000-819-654	⤷ Get Started Free
Hangzhou APIChem Technology	⤷ Get Started Free	AC-7613	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: August 7, 2025

Introduction
CIPRO XR, a once-daily extended-release formulation of ciprofloxacin, is a widely prescribed fluoroquinolone antibiotic used to treat various bacterial infections, including urinary tract infections, respiratory tract infections, and skin infections. Central to its formulation is the active pharmaceutical ingredient (API), ciprofloxacin, which is sourced globally from numerous suppliers. This article offers a comprehensive analysis of the primary sources of ciprofloxacin API suitable for CIPRO XR manufacturing, emphasizing quality standards, sourcing considerations, and market dynamics critical for pharmaceutical stakeholders.

Understanding Ciprofloxacin API and Its Importance in CIPRO XR

Ciprofloxacin API serves as the foundational atom on which CIPRO XR’s efficacy rests. Producing an extended-release formulation like CIPRO XR necessitates high-quality, pharmaceutical-grade ciprofloxacin with consistent bioavailability and release characteristics. The API’s purity, particle size, polymorphic form, and stability are crucial parameters that influence not only therapeutic performance but also manufacturing feasibility.

Global API Suppliers for Ciprofloxacin

1. Chinese Manufacturers

China remains a dominant force in the global pharmaceutical raw materials market, including ciprofloxacin API. Several Chinese firms are certified to produce ciprofloxacin API under international Good Manufacturing Practice (GMP) standards.

Key Players: Zhejiang Hisun Pharmaceutical, Shanghai Desano Pharmaceutical, and Zhejiang Huahai Pharmaceutical
Advantages: Cost competitiveness, large manufacturing capacities, extensive experience.
Quality Assurance: Many Chinese suppliers now obtain certifications such as US FDA, EMA, and ISO 9001 to meet international quality standards. However, due diligence remains vital given past concerns about quality variability.

2. Indian API Manufacturers

India is recognized for its robust pharmaceutical manufacturing capabilities, with a significant number of API producers adhering to international quality protocols.

Prominent Companies: Strides Shasun, Aurobindo Pharma, Cipla Limited, and Mankind Pharma.
Advantages: High-quality standards, robust regulatory compliance, innovative process development, and flexible supply chains.
Regulatory Status: Several Indian suppliers have received US FDA approval for their facilities, reflecting compliance with stringent international standards.

3. European and North American Suppliers

European and U.S.-based API manufacturers cater primarily to high-margin markets demanding the highest quality and regulatory assurance.

European Leaders: Recipharm (Sweden), Merck KGaA (Germany)
North American Suppliers: Sanofi (United States), Patheon (Canada)
Traceability & Reliability: These suppliers often provide APIs with advanced specifications, including characterized polymorphs and stability data suitable for extended-release formulations.

Key Considerations When Sourcing Ciprofloxacin API for CIPRO XR

Quality and Regulatory Compliance

Given the sensitive pharmacokinetics involved in extended-release formulations, sourcing API from GMP-compliant, fully validated facilities remains non-negotiable. Suppliers should provide comprehensive documentation, including:

Certificates of Analysis (CoA)
Stability data
Impurity profiles
Validation and audit reports

Particle Size and Polymorphic Form

The particle size distribution and polymorphic form significantly influence the API’s release profile. Suppliers capable of delivering specific particle sizes and polymorphs tailored for CIPRO XR are preferred to ensure formulation stability and consistent bioavailability.

Supply Chain Reliability

Continuity of supply is paramount, especially considering the globalized nature of pharmaceutical manufacturing. Establishing reliable long-term partnerships with multiple qualified suppliers helps mitigate risks related to shortages, regulatory compliance, and geopolitical factors.

Pricing and Lead Time

While quality takes precedence, competitive pricing and reasonable lead times are vital. Asian suppliers generally offer cost advantages, but procurement strategies should balance cost with regulatory and quality assurances.

Emerging Trends and Market Dynamics

The global ciprofloxacin API market exhibits evolving trends, including:

Integration of Green Chemistry: Suppliers adopting sustainable manufacturing practices align with current industry mandates.
Digital Validation and Traceability: Enhanced batch tracking and digital documentation facilitate compliance and reduce counterfeiting.
Regulatory Stringency: Increasing requirements for transparency and batch consistency influence supplier capabilities and market competition.

Market analysts project sustained demand for ciprofloxacin API, driven by ongoing antibiotic needs and the expansion of extended-release formulations like CIPRO XR. Consequently, suppliers investing in capacity expansion and quality modernization are positioned for long-term growth.

Regulatory and Quality Certification Landscape

Manufacturers supplying ciprofloxacin API for pharmaceutical use in CIPRO XR must meet strict regulatory standards. Notable certifications include:

GMP Certification (WHO, FDA, EMA): Ensures manufacturing processes adhere to international quality benchmarks.
ISO Certifications: ISO 9001 for quality management, ISO 14001 for environmental management.
Pharmacopoeial Compliance: API must conform to pharmacopoeial monographs (USP, EP, BP).

Alignment with these standards ensures the API’s suitability for manufacturing high-quality CIPRO XR products.

Sourcing Strategies for Pharmaceutical Companies

Supplier Qualification: Conduct rigorous audits, review regulatory history, and verify manufacturing capabilities.
Dual Sourcing: Engage multiple suppliers to reduce supply chain risks.
Long-term Partnerships: Establish ongoing collaborations with key manufacturers for stability and cost savings.
Technology Transfer: Collaborate on process validation and polymorph management to ensure API consistency.

Conclusion

Ciprofloxacin API sourcing for CIPRO XR demands strategic evaluation of supplier quality, regulatory adherence, supply continuity, and cost. Leading suppliers from China and India dominate the market, with reputable European and North American manufacturers serving high-end segments. Emphasizing quality, compliance, and supply security ensures integrated success from API sourcing to product launch.

Key Takeaways

Quality Assurance is Paramount: Only source ciprofloxacin API from GMP-certified suppliers with comprehensive documentation and stability data.
Diversify Suppliers: Establish relationships with multiple qualified vendors to mitigate supply chain risks.
Focus on API Specifics: Ensure particle size and polymorphic form compatibility for extended-release formulations.
Align with Regulatory Standards: Verify certifications such as ISO, WHO GMP, and pharmacopoeial compliance to facilitate global market approvals.
Market Trends Favor Innovation: Suppliers adopting sustainable practices and digital traceability will possess a competitive edge.

FAQs

1. What are the primary manufacturing regions for ciprofloxacin API?
China and India lead in ciprofloxacin API manufacturing, with a growing presence in Europe and North America for high-quality supplies.

2. How does API quality impact CIPRO XR’s formulation and efficacy?
High-quality API with consistent particle size, polymorphic form, and purity ensures predictable release profiles and therapeutic effectiveness in CIPRO XR.

3. What certifications should I verify when sourcing ciprofloxacin API?
Look for GMP certification (WHO, FDA, EMA), ISO standards, and pharmacopoeial compliance (USP, EP, BP).

4. How can pharmaceutical companies ensure supply continuity for ciprofloxacin API?
By establishing relationships with multiple qualified suppliers, performing regular audits, and creating buffer stock strategies.

5. What trends are influencing the ciprofloxacin API market?
Sustainable manufacturing, digital traceability, regulatory stringency, and increased demand for extended-release antibiotics shape market dynamics.

References
[1] Market research reports on pharmaceutical APIs, 2022-2023.
[2] World Health Organization (WHO) GMP guidelines.
[3] US FDA Database on approved API manufacturers.
[4] European Pharmacopoeia monograph for Ciprofloxacin.
[5] Industry analyses on the global fluoroquinolone antibiotic market.

Bulk Pharmaceutical API Sources for CIPRO XR